Head-to-Head

Amylyx Pharmaceuticals, Inc. Common Stock vs. Eli Lilly & Co.

AMLX

Amylyx Pharmaceuticals, Inc. Common Stock

$29.49 -2.16%

VS LLY

Eli Lilly & Co.

$1183.46 +0.13%

Eli Lilly & Co. (LLY) comes out ahead, leading on 4 of 7 compared factors.

Size & Scale

AMLXLLY
Market Cap $3.76 billion $1.05 trillion
Revenue (TTM) — $79.67 billion
Net Income (TTM) $-152,092,000 $26.71 billion

LLY leads on 3 of 3 size & scale factors.

Valuation

AMLXLLY
P/E Ratio — 39.73
Price / Book 15.74 31.14
Price / Sales — 13.24

AMLX leads on 1 of 1 valuation factors.

Profitability

AMLXLLY
Net Margin — 33.53%
Return on Equity -63.59% 78.84%

LLY leads on 1 of 1 profitability factors.

Dividend

AMLXLLY
Dividend Yield 5.69% 0.58%
Payout Ratio — 23.23

AMLX leads on 1 of 1 dividend factors.

Risk & Sentiment

AMLXLLY
Short Interest 0.00% 1.29%

AMLX leads on 1 of 1 risk & sentiment factors.

Dig deeper: AMLX overview, AMLX financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.